Dr. Thom George discusses colorectal cancer
Dr. Thomas George, Medical Director of GI Oncology Program at the University of Florida and a NSABP Principal Investigator discusses his relationship with NSABP, clinical trials for MSI-high colorecta... Author: NSABP_Foundation Added: 03/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Microsatellite Instability in Colorectal Cancer PD-1 Inhibitors have a significant response rate
Marwan Fakih, MD, explains Microsatellite Instability in Colorectal Cancer PD-1 Inhibitors have a significant response rate at the 2018 Oncology Summit in Huntington Beach, CA <br /><br />Go to: <a target='_blank' href='http://www.mo'>http://www.mo...</a>... Author: moasc Added: 03/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Investigating the Tumor Immune Response to Optimize Treatment in Colorectal Cancer
Marwan Fakih, MD, explains Investigating the Tumor Immune Response to Optimize Treatment in Colorectal Cancer at the 2018 Oncology Summit in Huntington Beach, CA <br /><br />Go to: <a target='_blank' href='http://www.moasc.org'>http://www.moasc.org...</a> for mo... Author: moasc Added: 03/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 6, 2018 Category: Cancer & Oncology Source Type: podcasts

MABp1: 'Clever' New Antibody Targeting Colorectal Cancer
A trial using MABp1, an antibody targeting interleukin 1 alpha, showed some benefit for patients with advanced colorectal cancer, but Dr Kerr thinks the clinical endpoint used was a ' little soft. ' (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - February 14, 2018 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts

IDEA Trial Remakes Adjuvant Chemo in Colorectal Cancer
Dr David Kerr on how one of the biggest studies at ASCO is already changing practice. (Source: Medscape Oncology)
Source: Medscape Oncology - February 9, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Practice-Changing Regorafenib Data at 2018 GI Cancers Symposium
Dr John Marshall discusses new science in pancreatic and colorectal cancers, presented at the 2018 Gastrointestinal Cancers Symposium. (Source: Medscape Oncology)
Source: Medscape Oncology - January 31, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Combo Cobimetinib & Atezolizumab in Metastatic Colorectal Cancer 8Response Rate with an Overall Survival of 13-14 months
Cathy Eng, MD, FACP GASTROINTESTINAL MEDICAL ONCOLOGY - MD Anderson discusses the combination of Cobimetinib & Atezolizumab in Metastatic Colorectal Cancer with an 8% Response Rate with an Overall Sur... Author: Gastrointestinal-Cancer-Meeting Added: 01/25/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2018 Category: Cancer & Oncology Source Type: podcasts

JAMA Oncology : Dietary Inflammatory Potential and Risk of Colorectal Cancer in Men and Women
Interview with Fred K. Tabung, and Charles S. Fuchs, MD, MPH, authors of Association of Dietary Inflammatory Potential With Colorectal Cancer Risk in Men and Women (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 18, 2018 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

JAMA Oncology : Preoperative vs Postoperative CEA and Colon Cancer Outcome
Interview with Martin R. Weiser, MD, author of Association of Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - December 21, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

Improved Insurance Access Increases Elective Colon Resection Rates
A new analysis proves that the Massachusetts health insurance ' experiment ' resulted in better cancer care. (Source: Medscape Oncology)
Source: Medscape Oncology - November 16, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Stage III CRC: Which Patients Need 6 Months of Adjuvant Chemo?
At the ESMO 2017 Congress in Madrid, Drs Sobrero and Taieb discuss the optimal duration of adjuvant chemotherapy for stage III colon cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - November 16, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

A Strategic Merger in Cancer Screening
A recent study relates future risk to current risk for advanced colorectal cancer. Dr Kerr suggests adding genetic testing to further improve diagnosis. (Source: Medscape Oncology)
Source: Medscape Oncology - October 18, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Debate: Is circulating tumor DNA ready to guide adjuvant therapy in colon cancer? - Yes
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Axel Grothey argues that circulating tumor DNA is ready to guide adjuvant therapy in colon cancer.<br /><br />Earn CME Credit... Author: imedex Added: 10/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Update: Left versus right sided colon cancers: Biomarkers vs. biology
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Scott Kopetz discusses the difference in the sided-ness of colon cancers and whether biomarkers or biology are more r... Author: imedex Added: 10/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Debate: Is there an optimal treatment for refractory colorectal cancer? - Immunotherapy
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Axel Grothey argues that immunotherapy is the optimal treatment for refractory colorectal cancer.<br /><br />Earn CME Credit ... Author: imedex Added: 10/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 13, 2017 Category: Cancer & Oncology Source Type: podcasts